Literature DB >> 12864724

Baseline data in clinical trials.

David C Burgess1, Val J Gebski, Anthony C Keech.   

Abstract

Mesh：

Year:  2003        PMID： 12864724     DOI： 10.5694/j.1326-5377.2003.tb05447.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  6 in total

1.  Assessment of pre- and post-methionine load homocysteine for prediction of recurrent stroke and coronary artery disease in the Vitamin Intervention for Stroke Prevention Trial.

Authors:  Luther C Pettigrew; Heejung Bang; Lloyd E Chambless; Virginia J Howard; James F Toole
Journal:  Atherosclerosis       Date:  2007-12-31       Impact factor: 5.162

2.  Evaluation of wet-cupping therapy for persistent non-specific low back pain: a randomised, waiting-list controlled, open-label, parallel-group pilot trial.

Authors:  Jong-In Kim; Tae-Hun Kim; Myeong Soo Lee; Jung Won Kang; Kun Hyung Kim; Jun-Yong Choi; Kyung-Won Kang; Ae-Ran Kim; Mi-Suk Shin; So-Young Jung; Sun-mi Choi
Journal:  Trials       Date:  2011-06-10       Impact factor: 2.279

3.  Appropriate design of research and statistical analyses: observational versus experimental studies.

Authors:  Hyun Kang
Journal:  Korean J Anesthesiol       Date:  2013-08

4.  Employing open/hidden administration in psychotherapy research: A randomized-controlled trial of expressive writing.

Authors:  Theresa Tondorf; Lisa-Katrin Kaufmann; Alexander Degel; Cosima Locher; Johanna Birkhäuer; Heike Gerger; Ulrike Ehlert; Jens Gaab
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

5.  Mindfulness-based cognitive therapy for inflammatory bowel disease patients: findings from an exploratory pilot randomised controlled trial.

Authors:  Mariyana Schoultz; Iain Atherton; Angus Watson
Journal:  Trials       Date:  2015-08-25       Impact factor: 2.279

6.  The use of mindfulness-based cognitive therapy for improving quality of life for inflammatory bowel disease patients: study protocol for a pilot randomised controlled trial with embedded process evaluation.

Authors:  Mariyana Schoultz; Iain M Atherton; Gill Hubbard; Angus J M Watson
Journal:  Trials       Date:  2013-12-17       Impact factor: 2.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.